BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ER, estrogen receptor AND Clinical Outcome
16 results:

  • 1. clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
    Yin L; Yin AH; Pu CC
    BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BRAF
    Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
    Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
    Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
    Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Analysis of factors influencing the clinical outcome after surgery and
    Li Y; Rao M; Zheng C; Huang J; Fang D; Xiong Y; Yuan G
    Front Endocrinol (Lausanne); 2022; 13():1015798. PubMed ID: 36313750
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nuclear hormone receptors in demyelinating diseases.
    Zorrilla Veloz RI; McKenzie T; Palacios BE; Hu J
    J Neuroendocrinol; 2022 Jul; 34(7):e13171. PubMed ID: 35734821
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Potential Impact of Body Mass Index on the clinical outcome of Papillary thyroid cancer After High-Dose Radioactive Iodine Therapy.
    Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
    Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
    Na-Er A; Xu YY; Liu YH; Gan YJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer.
    Zenan H; Zixiong L; Zhicheng Y; Mei H; Xiongbin Y; Tiantian W; Min D; Renbin L; Changchang J
    J Cell Physiol; 2019 Nov; 234(11):20584-20602. PubMed ID: 31016756
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
    Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
    J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Delayed initial radioiodine therapy related to incomplete response in low- to intermediate-risk differentiated thyroid cancer.
    Li H; Zhang YQ; Wang C; Zhang X; Li X; Lin YS
    Clin Endocrinol (Oxf); 2018 Apr; 88(4):601-606. PubMed ID: 29338092
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. clinical outcome of Radioiodine Therapy in Low-intermediate Risk Papillary thyroid Carcinoma with BRAF(V600E) Mutation.
    Li J; Yang T; Zhao T; Liang J; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):346-50. PubMed ID: 27544995
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. clinical outcome of (131)I Therapy in Differentiated thyroid cancer with Preablative Thyroglobulin below 10 ng/ml.
    Liu XF; Li J; Zhao T; Hou M; Li H; Liang J; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):88-92. PubMed ID: 26956863
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
    Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
    Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
    Kavanagh DO; McIlroy M; Myers E; Bane F; Crotty TB; McDermott E; Hill AD; Young LS
    Endocr Relat Cancer; 2010 Mar; 17(1):255-64. PubMed ID: 20032008
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
    Kansakar E; Chang YJ; Mehrabi M; Mittal V
    Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy.
    Mira-y-Lopez R; Osborne MP; DePalo AJ; Ossowski L
    Int J Cancer; 1991 Apr; 47(6):827-32. PubMed ID: 1901298
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.